A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer

Abstract Purpose An earlier multicenter phase III study demonstrated the safety and efficacy of mitoxantrone hydrochloride injection for tracing (MHI) for detecting sentinel lymph nodes (SLNs) in breast cancer patients. This ancillary study was conducted to further analyze and discover differences b...

Full description

Saved in:
Bibliographic Details
Main Authors: Dechuang Jiao, Xiuchun Chen, Xianfu Sun, Zhenduo Lu, Hao Dai, Chengzheng Wang, Chongjian Zhang, Lianfang Li, Jianghua Qiao, Zhenzhen Liu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13618-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861954743107584
author Dechuang Jiao
Xiuchun Chen
Xianfu Sun
Zhenduo Lu
Hao Dai
Chengzheng Wang
Chongjian Zhang
Lianfang Li
Jianghua Qiao
Zhenzhen Liu
author_facet Dechuang Jiao
Xiuchun Chen
Xianfu Sun
Zhenduo Lu
Hao Dai
Chengzheng Wang
Chongjian Zhang
Lianfang Li
Jianghua Qiao
Zhenzhen Liu
author_sort Dechuang Jiao
collection DOAJ
description Abstract Purpose An earlier multicenter phase III study demonstrated the safety and efficacy of mitoxantrone hydrochloride injection for tracing (MHI) for detecting sentinel lymph nodes (SLNs) in breast cancer patients. This ancillary study was conducted to further analyze and discover differences between the two tracers that had not been reported previously. Methods This analysis used single-center data from a phase III trial. Patients with breast cancer were injected with both MHI and 99mTc as SLN tracers before surgery. To account for cluster effects of multiple SLNs from the same patient and further analyze the differences between the two methods and factors that could impact detection, Obuchowski’s modified McNemar test, the GLIMMIX model, and univariate and multivariate analyses were used as appropriate. Results In total, 463 SLNs from 109 patients were resected, 47 of which were pathologically positive. The SLN detection rate did not significantly differ between MHI and 99mTc. MHI blue staining was an independent predictor of pathological positivity (OR 3.58, 95% CI: 1.21–10.60, p = 0.02), while the 99mTc signal was not significant in the same model (p = 0.39). Conclusion MHI was comparable to 99mTc in safety and SLN detection rates but differed in sensitivity on positive SLNs.
format Article
id doaj-art-41945b89dbd24ee0b6b383f03607535d
institution Kabale University
issn 1471-2407
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-41945b89dbd24ee0b6b383f03607535d2025-02-09T12:41:32ZengBMCBMC Cancer1471-24072025-02-012511710.1186/s12885-025-13618-xA comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancerDechuang Jiao0Xiuchun Chen1Xianfu Sun2Zhenduo Lu3Hao Dai4Chengzheng Wang5Chongjian Zhang6Lianfang Li7Jianghua Qiao8Zhenzhen Liu9Department of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalDepartment of Breast Disease, Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer HospitalAbstract Purpose An earlier multicenter phase III study demonstrated the safety and efficacy of mitoxantrone hydrochloride injection for tracing (MHI) for detecting sentinel lymph nodes (SLNs) in breast cancer patients. This ancillary study was conducted to further analyze and discover differences between the two tracers that had not been reported previously. Methods This analysis used single-center data from a phase III trial. Patients with breast cancer were injected with both MHI and 99mTc as SLN tracers before surgery. To account for cluster effects of multiple SLNs from the same patient and further analyze the differences between the two methods and factors that could impact detection, Obuchowski’s modified McNemar test, the GLIMMIX model, and univariate and multivariate analyses were used as appropriate. Results In total, 463 SLNs from 109 patients were resected, 47 of which were pathologically positive. The SLN detection rate did not significantly differ between MHI and 99mTc. MHI blue staining was an independent predictor of pathological positivity (OR 3.58, 95% CI: 1.21–10.60, p = 0.02), while the 99mTc signal was not significant in the same model (p = 0.39). Conclusion MHI was comparable to 99mTc in safety and SLN detection rates but differed in sensitivity on positive SLNs.https://doi.org/10.1186/s12885-025-13618-xSentinel lymph node biopsySLN99mTcMitoxantrone hydrochloride injection for tracingBreast cancer
spellingShingle Dechuang Jiao
Xiuchun Chen
Xianfu Sun
Zhenduo Lu
Hao Dai
Chengzheng Wang
Chongjian Zhang
Lianfang Li
Jianghua Qiao
Zhenzhen Liu
A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
BMC Cancer
Sentinel lymph node biopsy
SLN
99mTc
Mitoxantrone hydrochloride injection for tracing
Breast cancer
title A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
title_full A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
title_fullStr A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
title_full_unstemmed A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
title_short A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer
title_sort comparative study of mitoxantrone hydrochloride injection and technetium 99 m for tracing axillary sentinel nodes in patients with breast cancer
topic Sentinel lymph node biopsy
SLN
99mTc
Mitoxantrone hydrochloride injection for tracing
Breast cancer
url https://doi.org/10.1186/s12885-025-13618-x
work_keys_str_mv AT dechuangjiao acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT xiuchunchen acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT xianfusun acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT zhenduolu acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT haodai acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT chengzhengwang acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT chongjianzhang acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT lianfangli acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT jianghuaqiao acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT zhenzhenliu acomparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT dechuangjiao comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT xiuchunchen comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT xianfusun comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT zhenduolu comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT haodai comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT chengzhengwang comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT chongjianzhang comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT lianfangli comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT jianghuaqiao comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer
AT zhenzhenliu comparativestudyofmitoxantronehydrochlorideinjectionandtechnetium99mfortracingaxillarysentinelnodesinpatientswithbreastcancer